The Biotechnology R&D Intensity in the Business Sector in Switzerland is forecasted to decrease slightly from 0.03% of Value Added in Industry in 2024 to 0.025% in 2028. This denotes a year-on-year decline of approximately 6.67% from 2024 to 2025, followed by a smaller annual decrease of around 3.57% for the next three years. Furthermore, the 5-year CAGR from 2024 to 2028 shows an average annual reduction of 3.46% in R&D intensity.
Future trends to watch for include potential shifts in economic policies affecting biotech investment, advancements in biotech technology that could alter R&D efficiency, and global competitive pressures which might influence Switzerland's biotech R&D strategies. Watching regulatory changes, market demand for biotech solutions, and international collaboration efforts should also be closely monitored.
